AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-94059814/cancer-immunotherapy-company-chooses.html" title="Facts and information about Cancer immunotherapy company chooses new communications firm.">Cancer immunotherapy company chooses new communications firm.</a>
Close
Set up an RSS feed that alerts you when new articles from Vaccine Weekly are available.
Frequently asked questions about RSS feeds
Cancer immunotherapy company chooses new communications firm.
2002 NOV 13 - (NewsRx.com & NewsRx.net) -- Genitope Corp. has selected Dorland Global Health Communications as its agency of record, Dorland announced.
Genitope Corp. is a biotechnology company that focuses on discovering and developing personalized immunotherapies for the treatment of cancer. Dorland will provide marketing and public relations support to Genitope, including branding and clinical communications.
...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Market Commentary on Genitope Corp.
- Press release article from: M2 Presswire March 30, 2007 700+ words
...Biotech News: Market Commentary on Genitope Corp(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:30032007 Market Commentary on Genitope Corp (NASDAQ:GTOP) Genitope Corporation...the most up to date information on Genitope Corp are invited to sign up for a free complimentary...
- Investor Alert for Genitope Corp.
- Press release article from: M2 Presswire April 23, 2007 700+ words
...Biotech News: Investor Alert for Genitope Corp.(C)1994-2007 M2 COMMUNICATIONS...the most up to date information on Genitope Corp. are invited to sign up for a free...card needed! Biotechnology company Genitope Corp. on Thursday said it plans a public...
- BWR Begins Tracking Genitope Corp.
- Press release article from: M2 Presswire February 28, 2007 700+ words
...Biotech News: BWR Begins Tracking Genitope Corp.(C)1994-2007 M2 COMMUNICATIONS...the most up to date information on Genitope Corp. are invited to sign up for a free...archived for 30 days. More information on Genitope Corp. available in the members section...
- Genitope Corp. Planning a Public Offering.
- Press release article from: M2 Presswire April 23, 2007 700+ words
...PRESSWIRE-23 April 2007-NASDAQNEWS: Genitope Corp. Planning a Public Offering(C...members? Are you a shareholder of Genitope Corp. (NASDAQ:GTOP)? Join the many...subscription. Biotechnology company Genitope Corp. on Thursday said it plans a public...
- Other News To Note.(Advanced Viral Research Corp.)(Affymetrix Inc.)(Genitope...
- Magazine article from: BIOWORLD Today December 28, 2004 700+ words
...instrument and array manufacturing facilities and the September IVD CE marking of the instrument system in the European Union. Genitope Corp., of Redwood City, Calif., completed its sale of 4.25 million unregistered shares of newly issued common stock at...
- Dendreon Shares Surge, As Do Others In Cancer Immunotherapy.
- Magazine article from: BIOWORLD Today Lorenzo, Aaron April 2, 2007 700+ words
...Friday's top value gainer beyond Dendreon. Its prostate cancer immunotherapy, called GVAX, is staged just behind Provenge. The product...stock (NASDAQ:FVRL) climb 17 percent to $3.07. Genitope Corp., a Redwood City, Calif.-based company developing...
- Research and Markets: Analysis of Cancer Immunotherapy: Numerous Strategic...
- Press release article from: Business Wire April 26, 2004 700+ words
...the addition of Analysis of Cancer Immunotherapy: The World Guide to their offering. Analysis of Cancer Immunotherapy: The World Guide" offers...possibilities that have emerged in cancer immunotherapy. It is at the same time a...
- Research and Markets: The Global Structure of Cancer Immunotherapy R&D.
- Press release article from: Business Wire May 5, 2004 700+ words
...The Global Structure of Cancer Immunotherapy R&D to their offering. The Global Structure of Cancer Immunotherapy R& D is one of the...R& D situation in cancer immunotherapy. Information about new...
Source: HighBeam Research, Cancer immunotherapy company chooses new communications firm.